3D Imaging of Neonatal Faces
3D Imaging of Neonatal Subjects
1 other identifier
observational
18
1 country
1
Brief Summary
Facial scans of newborns will be performed before and after implementation of respiratory support devices such as nasal CPAP. 3D scanned images will be processed by Fisher \& Paykel Healthcare Limited. Images will be analyzed for changes or distortion in nasal structure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 30, 2015
CompletedFirst Posted
Study publicly available on registry
November 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJuly 25, 2016
July 1, 2016
8 months
October 30, 2015
July 22, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Deformation changes in nares of preterm infants that require ncpap
3D scans of infants face will be performed before implementation of NCPAP and a 3D scan will be performed after the NCPAP is discontinued and the images will be analyzed for changes in facial structures that might be due to NCPAP.
Up to 6 months
Other Outcomes (5)
Gestational Age at time of CPAP
Up to 6 months
Photograph of nose with scaled ruler
Up to 6 months
Initial 3D scan
Up to 6 months
- +2 more other outcomes
Study Arms (1)
Newborns requiring ncpap
3D scan of nares will be performed before and after administration of NCPAP for infants with Corrected Gestational Age greater than or equal to 24 weeks and less than or equal to 42 weeks.
Interventions
3D scan of subjects nose prior to implementation of ncpap and upon discontinuation of ncpap.
Eligibility Criteria
Infants between 24 and 42 weeks corrected gestational age and admitted to Sharp Mary Birch NICU.
You may qualify if:
- Infants between 24 and 42 weeks corrected gestational age (inclusive) born at Sharp Mary Birch NICU,
- Signed informed consent form
You may not qualify if:
- Nasally intubated infants
- Infants with craniofacial abnormalities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sharp HealthCarelead
- Fisher and Paykel Healthcarecollaborator
Study Sites (1)
Sharp Mary Birch Hospital for Women and Newborns
San Diego, California, 92123, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Neonatal Research
Study Record Dates
First Submitted
October 30, 2015
First Posted
November 13, 2015
Study Start
October 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
July 25, 2016
Record last verified: 2016-07